AmerisourceBergen, a Chesterbrook, Pennsylvania based drug wholesale company could exceed the threshold of USD 56.3.
Regarding the fundamentals, the group is in a good financial situation. Sales are expected to rise by 9.3% on the current year with an EPS of USD 2.80. The company is relatively undervalued with a ratio "Enterprise value/revenue" of 0.15x.
Technically, the stock is moving in an upward trend for many months. This movement reflects a buyer enthusiasm confirmed also by the well orientation of moving averages. The security is going toward USD 56.3 and would give a strong buying signal if the crossing is confirmed in daily closing.
Therefore, investors will benefit from the signal given by the crossing of the USD 56.3 resistance to take a long position in the stock. The objective will be set near USD 61. Once the position is opened, a stop loss should be fixed under effective entry point to guard against a trend reversal.
Cencora, Inc. specializes in distributing pharmaceutical products. The group supplies generic and name-brand medications, OTC healthcare products, and home care equipment to healthcare providers (hospitals, clinics, pharmacies, physicians, etc.) located in the United States and Canada. The group also offers services to physicians and patients (support and reimbursement assistance services, prescription management services, nursing services, home injection and perfusion services, etc.).
CENCORA, INC. 
